Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA ...
Investing.com -- Shares of drugmaker Cumberland Pharmaceuticals (NASDAQ:CPIX) rose 15.04% to $4.36 on Wednesday after the ...
ETHealthworld.com brings latest duchenne muscular dystrophy news, views and updates from all top sources for the Indian Health industry.
Surgical correction of scoliosis in patients with DMD remains controversial. This retrospective study enrolled patients who underwent posterior instrumented spinal fusion to correct spinal deformity ...
Your muscles need continuous maintenance to stay strong and healthy. Duchenne muscular dystrophy (DMD) happens when there is a change in a person's genetic instructions that affects the production of ...
Stocktwits on MSN
ATOS stock tumbles 32% — here’s what retail investors think of the reverse stock split
Each of 15 shares of the company’s common stock outstanding was combined into one new share of common stock. ・No fractional ...
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...
"The incidence of DMD in our study was similar to that reported in previous studies . . . Overall, our results indicate that newborn screening for DMD is feasible, and this will be good news for the ...
From imaging innovations to new treatment approvals, 2024 brought advancements in Duchenne muscular dystrophy care and research. This year’s top stories on Duchenne muscular dystrophy (DMD) managed ...
Duchenne muscular dystrophy (DMD) is a genetic condition that causes increasing muscle weakness over time. While DMD currently has no cure, researchers are studying potential new treatments. When ...
An evidence-based event model for Duchenne muscular dystrophy in the United States Characterizing the natural history of Duchenne muscular dystrophy in the United States in real-world commercial and ...
KYOTO--Utilizing genome editing technology, a team of researchers has developed a much more effective treatment for a certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results